| Dr Kaley Myer, MD | |
|
304 W Bay Dr Nw Ste 301, Olympia, WA 98502-4957 | |
| (360) 413-8760 | |
| Not Available |
| Full Name | Dr Kaley Myer |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 11 Years |
| Location | 304 W Bay Dr Nw Ste 301, Olympia, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164869459 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 53343 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dermatology And Allergy Specialists | 1254302698 | 7 |
News Archive
In response to today's New York Times article, "Hope against Hepatitis C," Andrew Muir, M.D., M.H.S., Director, Gastroenterology/Hepatology Research, Duke Clinical Research Institute and Steering Committee Member of the National Viral Hepatitis Roundtable (NVHR) released the following statement:
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.
Acorda Therapeutics, Inc. today announced that the Company has partnered with Watson Pharma, Inc., a subsidiary of Watson Pharmaceuticals, Inc. to introduce tizanidine hydrochloride capsules, an authorized generic version of ZANAFLEX CAPSULES (tizanidine hydrochloride).
A UMass Lowell researcher has been awarded a $2.48 million grant to develop advances in safety for home care aides and clients that will keep pace with an aging population, advances in technology and other factors that are rapidly changing the field.
› Verified 4 days ago
| Entity Name | Dermatology & Allergy Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497755797 PECOS PAC ID: 1254302698 Enrollment ID: O20040802000365 |
News Archive
In response to today's New York Times article, "Hope against Hepatitis C," Andrew Muir, M.D., M.H.S., Director, Gastroenterology/Hepatology Research, Duke Clinical Research Institute and Steering Committee Member of the National Viral Hepatitis Roundtable (NVHR) released the following statement:
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.
Acorda Therapeutics, Inc. today announced that the Company has partnered with Watson Pharma, Inc., a subsidiary of Watson Pharmaceuticals, Inc. to introduce tizanidine hydrochloride capsules, an authorized generic version of ZANAFLEX CAPSULES (tizanidine hydrochloride).
A UMass Lowell researcher has been awarded a $2.48 million grant to develop advances in safety for home care aides and clients that will keep pace with an aging population, advances in technology and other factors that are rapidly changing the field.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kaley Myer, MD 304 W Bay Dr Nw Ste 301, Olympia, WA 98502-4957 Ph: (360) 413-8760 | Dr Kaley Myer, MD 304 W Bay Dr Nw Ste 301, Olympia, WA 98502-4957 Ph: (360) 413-8760 |
News Archive
In response to today's New York Times article, "Hope against Hepatitis C," Andrew Muir, M.D., M.H.S., Director, Gastroenterology/Hepatology Research, Duke Clinical Research Institute and Steering Committee Member of the National Viral Hepatitis Roundtable (NVHR) released the following statement:
Immunomedics, Inc., a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that TF12, in combination with radiolabeled peptides, produced specific, fast, high-contrast imaging and pretargeted radioimmunotherapy of epithelial cancers that include cancers of the prostate and the ovary.
Acorda Therapeutics, Inc. today announced that the Company has partnered with Watson Pharma, Inc., a subsidiary of Watson Pharmaceuticals, Inc. to introduce tizanidine hydrochloride capsules, an authorized generic version of ZANAFLEX CAPSULES (tizanidine hydrochloride).
A UMass Lowell researcher has been awarded a $2.48 million grant to develop advances in safety for home care aides and clients that will keep pace with an aging population, advances in technology and other factors that are rapidly changing the field.
› Verified 4 days ago
David A Remis, Dermatology Medicare: Not Enrolled in Medicare Practice Location: 700 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-923-7000 | |
Dr. Vivian A Lombillo, MD PHD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 703 Lilly Rd Ne Suite 105, Northwest Pediatric Dermatology, Pllc, Olympia, WA 98506 Phone: 360-539-6141 | |
Shauna M Richert, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 304 W Bay Dr Nw, Suite 301, Olympia, WA 98502 Phone: 360-413-8760 Fax: 360-413-8839 | |
Dr. James L Brazil, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 424 Lilly Rd Ne, Olympia, WA 98506 Phone: 360-459-1700 Fax: 360-459-0537 | |
Dr. Jacob Howard Bauer, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 304 W Bay Dr Nw, Ste 301, Olympia, WA 98502 Phone: 360-413-8760 | |
Dr. James William Young, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 5127 Klahanie Dr Nw, Olympia, WA 98502 Phone: 360-866-4535 |